PharVision Advisers’s Duolingo DUOL Stock Holding History

PharVision Advisers’s Portfolio DUOL Stock Details DUOL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,319	Closed	-$231K	–	264
2025 Q4	$231K	Buy	+1,319	New	+$311K	0.12%	439

Other funds holding DUOL

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PharVision Advisers's DUOL Position: Q1 2026 in Review

PharVision Advisers sold out of Duolingo (DUOL) in Q1 2026, closing a stake of 1,319 shares — an estimated $231K sold.

PharVision Advisers first reported a position in DUOL in Q4 2025 and held it in 1 quarter. The position peaked at $231K in Q4 2025. 370 funds tracked by Wall St. Rank hold DUOL as of Q1 2026.

PharVision Advisers reported no remaining Duolingo position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 1,319 Duolingo shares in Q1 2026, an estimated $231K.
PharVision Advisers first reported a position in Duolingo in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Duolingo position peaked at $231K in Q4 2025.
370 funds tracked by Wall St. Rank held Duolingo as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.